Scientific & Clinical Advisors

Piton Therapeutics is guided by a world-class network of scientific and clinical advisors who are leaders in their respective fields, spanning immunology, neurology, microbiome science, pharmacology, and clinical development. Their expertise ensures our therapeutic strategies are grounded in cutting-edge science and aligned with real-world clinical needs. These trusted advisors provide critical insight that shapes our R&D priorities, informs our translational approach, and accelerates our path toward delivering impactful, precision-based therapies to patients.

Alessio Fasano, MD
Gastroenterology & Microbiome

Christopher McDougle, MD
Psychiatry & Autism

Andrew Goodman, Ph.D.
Microbial Genetics

Krishna Kumar, Ph.D.
Chemistry & Drug Development

Dong Kong, Ph.D.
Neuroscience & Gut-Brain Axis & Imaging Scientific Founder, Chairman of Board & SAB

Maude M. David, Ph.D.
Associate Professor
Department of Microbiology

Learn about Piton’s AI-powered platform


At Piton Therapeutics, we are revolutionizing precision medicine through our state-of-the-art AI-powered platform, unlocking novel small-molecule therapeutics that target the gut-brain axis with unparalleled specificity.